Belgian Task Force
Symposium
The completion of the Human Genome Project, the development of tools to study the role of DNA and of the information it contains in health and disease, commonly known as ‘genomic science’, and the ensuing advances in cell and molecular biology (together with new areas of research such as functional genomics) could have an important impact on the practice of medicine in the future. It is important for the correct implementation of this knowledge that realistic, evidence-based information about the clinical and health implications is provided to the public and the professionals, and that its application in public health does not lead to social injustice as a result of unaffordable costs, stigmatization or discrimination.
To ensure that there will be equity of access to clinical genetic services across Europe, an adequate capacity to respond to scientific developments in this field and a responsible – i.e. ethical, legal and socially acceptable – response to the conduct of the science and its eventual use to improve the health of individuals and populations, a series of measures will have to be taken by the European Member States (MS), preferably with support of the EU, that considers a stronger utilization of genome-based knowledge for health in its new health strategy, including rare inherited disorders .
To examine these questions at the Belgian level, a multi-stakeholder Task Force is organizing a symposium on this subject
Monday February 8, 2010
Zaal/Salle Storck
F.O.D. Werkgelegenheid, Arbeid en Sociaal Overleg,
S.P.F. Emploi, Travail et Concertation Sociale
Rue Ernest Blerotstraat 1 - 1070 Anderlecht
Meeting report available:
Nederlands
-
Français -
English
Meeting pictures available: View